{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pigmented-nodular-adrenocortical-disease-primary-1","columns":[{"gene":"","key":"population-2fec692b7a9c537ac3fa","label":"Pigmented nodular adrenocortical disease, primary, 1","mondoId":"MONDO:0012509","onsetQualifier":null,"originColumnKey":"MONDO:0012509/OMIM:610489","originalViews":[{"key":"MONDO:0012509/OMIM:610489","label":"Pigmented nodular adrenocortical disease, primary, 1","scopeLabel":"OMIM:610489","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0628c040909aa6d31d22862bc80171cd8427c334b1e10143179a29e78a7f8341","0cd8fef6e9f7383c5b8a713e046ec7eb7c4b1634336c53eed665f4b64775f944","10cb15c0928ba9858cbb38d1838156e3bec4d48d7d30d0117882708ebb785518","20b7537e9f70abf16aae1405fbd4e875be3377e827596ebe06bd990a2c9cc58c","21e43e5103e84bf129eecd5d3535596732d3a0cae38c51b39de2be2f1f66aaa0","3eb6b779ffaeb8bd5a77694eb96e37911a0b734bcdfea879494f6ea11d05a8ae","4456ff6e4b47a857e0fc28c8f27ea989c669bb92f94e1b3b4494422468493521","544e0f717667083fa5e80f8a087aa6d8f97e462fd25b21bf73beff3851c0f960","559a859d2a08a91a59974b340afe1a4c44a07b4ce75c25c5fd1ba1a6887dd6f1","5e903872ab01726d38702d3208fe9cf7a1bf8ed7462e68e2aad3b2b6387bde87","8f2cba4cb7db0393d02a241d99e6c0557f13f0392d638876641bf08022b256c5","99d3099f0f6cb7c08dbd40e37c6f7b9a55563478cad85edacd222e8a9f1ad0b1","a051168afa36598f24af32b0f66bd6f8e79bcbff9df471702dcee40bbb32db4d","a0cf8d4855cd27d11e4aa9d761731da483781d5aecfa57d7828bbc74a0cbafea","a373ff598613476da2f24c1d21fbe9aaa388e786de08bfdc406d0d91fb580154","a559a64a7d14af58a3fef8d50151e0f084dabd4db1467d2bf8c0360095e61f89","b695423fc7cf6f61cd78ada7462e1951551e932d16102daf262468758dac4ec4","c1c5b6b4cabca4cd8b0bd9ad3a0f644c5538d5337ac6d8e95205f822d6bf0721","d2bb698f66ef5c75ebe7fbb189f6fb26ff9bea007d8f1bf05efa2aae748daa59","d44e06dd6dca2260f8777444ca3f8fe8a360b3f4d95e985ba8a46ec72b418630","d987d2ab067acd6931d22f3ee7bdc91dd805bd07eaf97a9a7a4679f25ca298ae","e53c921151a6f87c56ae29e7e5507c4ddbe4e40ff10476b5f35e64e46ff260d8","e87959bcbf3d2fce38128affb7e534c2d1c5fdbb21e5d41460ce5c2660a63ea3","ee1478a4f42f3bbe3b8154bf4ef0042e839473570137758e79eeb197f1245000"],"recordQualifiers":{},"scopeLabel":"OMIM:610489","sourceIds":["OMIM:610489"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2fec692b7a9c537ac3fa"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000713","HP:0000739","HP:0000978","HP:0002920","HP:0031214","HP:0000716","HP:0000712"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"omim":19,"published":5}},"features":[{"hpoId":"HP:0000713","label":"Agitation","primary":true},{"hpoId":"HP:0000739","label":"Anxiety","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0002920","label":"Decreased circulating ACTH concentration","primary":true},{"hpoId":"HP:0031214","label":"Decreased circulating dehydroepiandrosterone concentration","primary":true},{"hpoId":"HP:0000716","label":"Depression","primary":true},{"hpoId":"HP:0000712","label":"Emotional lability","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0003118","label":"Increased circulating cortisol level","primary":false},{"hpoId":"HP:0030088","label":"Increased serum testosterone level","primary":false},{"hpoId":"HP:0012030","label":"Increased urinary cortisol level","primary":false},{"hpoId":"HP:0002808","label":"Kyphosis","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0000938","label":"Osteopenia","primary":false},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0003466","label":"Paradoxical increased cortisol secretion on dexamethasone suppression test","primary":false},{"hpoId":"HP:0001580","label":"Pigmented micronodular adrenocortical disease","primary":false},{"hpoId":"HP:0001579","label":"Primary hypercortisolism","primary":false},{"hpoId":"HP:0000709","label":"Psychosis","primary":false},{"hpoId":"HP:0000311","label":"Round face","primary":false},{"hpoId":"HP:0000869","label":"Secondary amenorrhea","primary":false},{"hpoId":"HP:0001065","label":"Striae distensae","primary":false},{"hpoId":"HP:0000963","label":"Thin skin","primary":false},{"hpoId":"HP:0001956","label":"Truncal obesity","primary":false}],"ledeHtml":"Any primary pigmented nodular adrenocortical disease in which the cause of the disease is a mutation in the PRKAR1A gene.","mondoId":"MONDO:0012509","node":{"canonicalSlug":"pigmented-nodular-adrenocortical-disease-primary-1","comparisons":[{"documentSha256":"8524a16eb22a3db4f265abbfbc5000cd4532a6d0c242309f0df09a9bec7f3d50","key":"legacy-primary-pigmented-nodular-adrenocortical-disease","kind":"legacy","label":"primary pigmented nodular adrenocortical disease","memberIds":["MONDO:0012505","MONDO:0012509","MONDO:0013616","MONDO:0014359","MONDO:0015999"],"mondoId":"MONDO:0015999","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/primary-pigmented-nodular-adrenocortical-disease.8524a16eb22a3db4f265abbfbc5000cd4532a6d0c242309f0df09a9bec7f3d50.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"pigmented nodular adrenocortical disease, primary, 1","paragraphs":["Any primary pigmented nodular adrenocortical disease in which the cause of the disease is a mutation in the PRKAR1A gene."],"scope":"exact","source":"MONDO","upstream":"MONDO:patterns/disease_series_by_gene","url":"https://monarchinitiative.org/MONDO:0012509"},"ownColumnKeys":["population-2fec692b7a9c537ac3fa"],"publication":"published","relationships":[{"kind":"parent","label":"primary pigmented nodular adrenocortical disease","mondoId":"MONDO:0015999","slug":"primary-pigmented-nodular-adrenocortical-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18620"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0628c040909aa6d31d22862bc80171cd8427c334b1e10143179a29e78a7f8341","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0cd8fef6e9f7383c5b8a713e046ec7eb7c4b1634336c53eed665f4b64775f944","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001579","is_excluded":false,"label":"Primary hypercortisolism","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"10cb15c0928ba9858cbb38d1838156e3bec4d48d7d30d0117882708ebb785518","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002920","is_excluded":false,"label":"Decreased circulating ACTH concentration","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"20b7537e9f70abf16aae1405fbd4e875be3377e827596ebe06bd990a2c9cc58c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0012030","is_excluded":false,"label":"Increased urinary cortisol level","onset_id":null,"reference":"PMID:12213893","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"21e43e5103e84bf129eecd5d3535596732d3a0cae38c51b39de2be2f1f66aaa0","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"PCS","frequency_raw":"2/4","hpo_id":"HP:0030088","is_excluded":false,"label":"Increased serum testosterone level","onset_id":null,"reference":"PMID:12213893","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3eb6b779ffaeb8bd5a77694eb96e37911a0b734bcdfea879494f6ea11d05a8ae","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000739","is_excluded":false,"label":"Anxiety","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"4456ff6e4b47a857e0fc28c8f27ea989c669bb92f94e1b3b4494422468493521","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0000869","is_excluded":false,"label":"Secondary amenorrhea","onset_id":null,"reference":"PMID:12213893","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"544e0f717667083fa5e80f8a087aa6d8f97e462fd25b21bf73beff3851c0f960","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001065","is_excluded":false,"label":"Striae distensae","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"559a859d2a08a91a59974b340afe1a4c44a07b4ce75c25c5fd1ba1a6887dd6f1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000712","is_excluded":false,"label":"Emotional lability","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5e903872ab01726d38702d3208fe9cf7a1bf8ed7462e68e2aad3b2b6387bde87","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000709","is_excluded":false,"label":"Psychosis","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8f2cba4cb7db0393d02a241d99e6c0557f13f0392d638876641bf08022b256c5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"99d3099f0f6cb7c08dbd40e37c6f7b9a55563478cad85edacd222e8a9f1ad0b1","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000963","is_excluded":false,"label":"Thin skin","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a051168afa36598f24af32b0f66bd6f8e79bcbff9df471702dcee40bbb32db4d","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000311","is_excluded":false,"label":"Round face","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a0cf8d4855cd27d11e4aa9d761731da483781d5aecfa57d7828bbc74a0cbafea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a373ff598613476da2f24c1d21fbe9aaa388e786de08bfdc406d0d91fb580154","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001580","is_excluded":false,"label":"Pigmented micronodular adrenocortical disease","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a559a64a7d14af58a3fef8d50151e0f084dabd4db1467d2bf8c0360095e61f89","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b695423fc7cf6f61cd78ada7462e1951551e932d16102daf262468758dac4ec4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000938","is_excluded":false,"label":"Osteopenia","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c1c5b6b4cabca4cd8b0bd9ad3a0f644c5538d5337ac6d8e95205f822d6bf0721","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001956","is_excluded":false,"label":"Truncal obesity","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d2bb698f66ef5c75ebe7fbb189f6fb26ff9bea007d8f1bf05efa2aae748daa59","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"PCS","frequency_raw":"3/4","hpo_id":"HP:0031214","is_excluded":false,"label":"Decreased circulating dehydroepiandrosterone concentration","onset_id":null,"reference":"PMID:12213893","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d44e06dd6dca2260f8777444ca3f8fe8a360b3f4d95e985ba8a46ec72b418630","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003118","is_excluded":false,"label":"Increased circulating cortisol level","onset_id":null,"reference":"PMID:12213893","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d987d2ab067acd6931d22f3ee7bdc91dd805bd07eaf97a9a7a4679f25ca298ae","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002808","is_excluded":false,"label":"Kyphosis","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e53c921151a6f87c56ae29e7e5507c4ddbe4e40ff10476b5f35e64e46ff260d8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e87959bcbf3d2fce38128affb7e534c2d1c5fdbb21e5d41460ce5c2660a63ea3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000713","is_excluded":false,"label":"Agitation","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ee1478a4f42f3bbe3b8154bf4ef0042e839473570137758e79eeb197f1245000","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610489","disease_name":"Pigmented nodular adrenocortical disease, primary, 1","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003466","is_excluded":false,"label":"Paradoxical increased cortisol secretion on dexamethasone suppression test","onset_id":null,"reference":"OMIM:610489","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012509\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>MONDO:patterns/disease_series_by_gene</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any primary pigmented nodular adrenocortical disease in which the cause of the disease is a mutation in the PRKAR1A gene.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012509\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"pigmented-nodular-adrenocortical-disease-primary-1","sourceDocuments":[{"name":"MONDO: pigmented nodular adrenocortical disease, primary, 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012509"}],"sourceNote":"","synonyms":["pigmented nodular adrenocortical disease, primary, 1","pigmented nodular adrenocortical disease, primary, type 1","PPNAD1","primary pigmented nodular adrenocortical disease caused by mutation in PRKAR1A","PRKAR1A primary pigmented nodular adrenocortical disease"],"takeawayHtml":"","title":"pigmented nodular adrenocortical disease, primary, 1"},"schemaVersion":1}
